(RACE) Ferrari - Ratings and Ratios
Sports Cars, Supercars, Parts, Services, Licensing
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.74% |
| Yield on Cost 5y | 3.04% |
| Yield CAGR 5y | 20.65% |
| Payout Consistency | 98.0% |
| Payout Ratio | 73.3% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 27.4% |
| Value at Risk 5%th | 41.6% |
| Relative Tail Risk | -7.96% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.25 |
| Alpha | -22.22 |
| CAGR/Max DD | 0.77 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.707 |
| Beta | 0.697 |
| Beta Downside | 0.454 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.67% |
| Mean DD | 6.54% |
| Median DD | 4.76% |
Description: RACE Ferrari December 03, 2025
Ferrari N.V. (NYSE:RACE) designs, engineers, manufactures, and sells luxury performance automobiles-including sports, track, one-off, and supercars-while also monetising its brand through spare-part sales, after-sales services, licensing agreements, and a portfolio of hospitality and experiential assets such as museums, a restaurant, and theme parks in Abu Dhabi and Spain. The company further offers financing, leasing, and ancillary financial services, and operates both franchised and company-owned retail stores worldwide. Founded in 1947, Ferrari is headquartered in Maranello, Italy.
Key recent metrics: FY 2023 revenue reached €5.6 billion, with an operating margin of roughly 20%, reflecting the premium pricing power of its limited-production model strategy. The firm’s “Ferrari 2025” roadmap targets a 30 % increase in hybrid and fully electric model output, aligning with tightening EU CO₂ regulations-a sector-wide driver that could reshape competitive dynamics. Additionally, Chinese ultra-high-net-worth individuals now account for about 15 % of total deliveries, making macro-level wealth-creation trends in Asia a material demand catalyst.
For a deeper, data-driven look at Ferrari’s valuation and how these drivers compare to peers, check out the detailed analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income (1.60b TTM) > 0 and > 6% of Revenue (6% = 424.8m TTM) |
| FCFTA 0.15 (>2.0%) and ΔFCFTA 3.76pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 37.90% (prev 27.49%; Δ 10.41pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.25 (>3.0%) and CFO 2.33b > Net Income 1.60b (YES >=105%, WARN >=100%) |
| Net Debt (1.45b) to EBITDA (2.63b) ratio: 0.55 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.30 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (178.3m) change vs 12m ago -0.83% (target <= -2.0% for YES) |
| Gross Margin 51.26% (prev 49.80%; Δ 1.47pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 76.66% (prev 71.91%; Δ 4.75pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 46.59 (EBITDA TTM 2.63b / Interest Expense TTM 44.5m) >= 6 (WARN >= 3) |
Altman Z'' 5.32
| (A) 0.28 = (Total Current Assets 4.74b - Total Current Liabilities 2.06b) / Total Assets 9.48b |
| (B) 0.39 = Retained Earnings (Balance) 3.67b / Total Assets 9.48b |
| (C) 0.22 = EBIT TTM 2.07b / Avg Total Assets 9.24b |
| (D) 0.66 = Book Value of Equity 3.77b / Total Liabilities 5.71b |
| Total Rating: 5.32 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 91.21
| 1. Piotroski 8.50pt |
| 2. FCF Yield 2.59% |
| 3. FCF Margin 20.76% |
| 4. Debt/Equity 0.76 |
| 5. Debt/Ebitda 0.55 |
| 6. ROIC - WACC (= 16.22)% |
| 7. RoE 44.44% |
| 8. Rev. Trend 97.37% |
| 9. EPS Trend 88.72% |
What is the price of RACE shares?
Over the past week, the price has changed by +3.04%, over one month by -2.96%, over three months by -21.12% and over the past year by -9.71%.
Is RACE a buy, sell or hold?
- Strong Buy: 5
- Buy: 3
- Hold: 4
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the RACE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 477.9 | 26.3% |
| Analysts Target Price | 477.9 | 26.3% |
| ValueRay Target Price | 412.6 | 9.1% |
RACE Fundamental Data Overview December 16, 2025
P/E Trailing = 34.9648
P/E Forward = 32.2581
P/S = 9.1935
P/B = 14.7407
P/EG = 3.7778
Beta = 0.625
Revenue TTM = 7.08b EUR
EBIT TTM = 2.07b EUR
EBITDA TTM = 2.63b EUR
Long Term Debt = 1.81b EUR (from longTermDebt, last quarter)
Short Term Debt = 930.6m EUR (from shortTermDebt, last quarter)
Debt = 2.88b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.45b EUR (from netDebt column, last quarter)
Enterprise Value = 56.73b EUR (55.39b + Debt 2.88b - CCE 1.54b)
Interest Coverage Ratio = 46.59 (Ebit TTM 2.07b / Interest Expense TTM 44.5m)
FCF Yield = 2.59% (FCF TTM 1.47b / Enterprise Value 56.73b)
FCF Margin = 20.76% (FCF TTM 1.47b / Revenue TTM 7.08b)
Net Margin = 22.63% (Net Income TTM 1.60b / Revenue TTM 7.08b)
Gross Margin = 51.26% ((Revenue TTM 7.08b - Cost of Revenue TTM 3.45b) / Revenue TTM)
Gross Margin QoQ = 50.05% (prev 52.64%)
Tobins Q-Ratio = 5.98 (Enterprise Value 56.73b / Total Assets 9.48b)
Interest Expense / Debt = 0.20% (Interest Expense 5.78m / Debt 2.88b)
Taxrate = 22.00% (107.7m / 489.4m)
NOPAT = 1.62b (EBIT 2.07b * (1 - 22.00%))
Current Ratio = 2.30 (Total Current Assets 4.74b / Total Current Liabilities 2.06b)
Debt / Equity = 0.76 (Debt 2.88b / totalStockholderEquity, last quarter 3.77b)
Debt / EBITDA = 0.55 (Net Debt 1.45b / EBITDA 2.63b)
Debt / FCF = 0.99 (Net Debt 1.45b / FCF TTM 1.47b)
Total Stockholder Equity = 3.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.90% (Net Income 1.60b / Total Assets 9.48b)
RoE = 44.44% (Net Income TTM 1.60b / Total Stockholder Equity 3.60b)
RoCE = 38.29% (EBIT 2.07b / Capital Employed (Equity 3.60b + L.T.Debt 1.81b))
RoIC = 24.40% (NOPAT 1.62b / Invested Capital 6.62b)
WACC = 8.17% (E(55.39b)/V(58.27b) * Re(8.59%) + D(2.88b)/V(58.27b) * Rd(0.20%) * (1-Tc(0.22)))
Discount Rate = 8.59% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.70%
[DCF Debug] Terminal Value 79.69% ; FCFE base≈1.30b ; Y1≈1.61b ; Y5≈2.74b
Fair Price DCF = 237.1 (DCF Value 42.03b / Shares Outstanding 177.3m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 88.72 | EPS CAGR: 17.74% | SUE: 0.96 | # QB: 1
Revenue Correlation: 97.37 | Revenue CAGR: 11.56% | SUE: 0.29 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.42 | Chg30d=-0.044 | Revisions Net=-2 | Analysts=2
EPS next Year (2026-12-31): EPS=9.73 | Chg30d=-0.268 | Revisions Net=-4 | Growth EPS=+8.5% | Growth Revenue=+7.2%
Additional Sources for RACE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle